Cellid

Risk score

57
Large logo of Cellid

Headquarters

Flag of South KoreaSouth Korea

Cellid is a research and development specialized bioventure firm founded in a laboratory within the college of pharmacy at Seoul National University. The company is dedicated to the advancement of innovative immunotherapeutic vaccines, known as CeliVax, designed to address the current medical and technical constraints of treating cancer and infectious diseases. CeliVax is a personalized vaccine utilizing the patient's own cells, demonstrating potent and effective immunotherapeutic properties that stimulate various immune cell types within our immune system while minimizing adverse effects. The primary objective is to enhance the quality of life for patients with persistent diseases.